Press Releases from DelveInsight Business Research LLP (5011 total)
Chronic Kidney Disease Clinical and Non-Clinical Studies, Key Companies, Therape …
Chronic Kidney Disease Pipeline constitutes 80+ key companies continuously working towards developing 85+ Chronic Kidney Disease treatment therapies, analyzes DelveInsight.
Chronic Kidney Disease Overview:
Chronic Kidney Disease…
Narcolepsy Clinical and Non-Clinical Studies, Key Companies, Therapeutic Assessm …
Narcolepsy Pipeline constitutes 15+ key companies continuously working towards developing 20+ Narcolepsy treatment therapies, analyzes DelveInsight.
Narcolepsy Overview:
Narcolepsy is a rare, long-term brain disorder that causes…
Malignant Pleural Mesothelioma Clinical and Non-Clinical Studies, Key Companies, …
Malignant Pleural Mesothelioma Pipeline constitutes 20+ key companies continuously working towards developing 20+ Malignant Pleural Mesothelioma treatment therapies, analyzes DelveInsight.
Malignant Pleural Mesothelioma Overview:
Malignant pleural mesothelioma…
Von Willebrand Disease Clinical and Non-Clinical Studies, Key Companies, Therape …
Von Willebrand Disease Pipeline constitutes 3 + key companies continuously working towards developing 3+ Von Willebrand Disease treatment therapies, analyzes DelveInsight.
Von Willebrand Disease Overview:
Von Willebrand disease…
HER2+ Gastric Cancer Clinical and Non-Clinical Studies, Key Companies, Therapeut …
HER2+ Gastric Cancer Pipeline constitutes 20+ key companies continuously working towards developing 20+ HER2+ Gastric Cancer treatment therapies, analyzes DelveInsight.
HER2+ Gastric Cancer Overview:
Gastric cancer ranks…
HPV16+ Cancer Clinical and Non-Clinical Studies, Key Companies, Therapeutic Asse …
HPV16+ Cancer Pipeline constitutes 10+ key companies continuously working towards developing 12+ HPV16+ Cancer treatment therapies, analyzes DelveInsight.
HPV16+ Cancer Overview:
Human papillomavirus 16 (HPV16) is a…
Osteomyelitis Clinical and Non-Clinical Studies, Key Companies, Therapeutic Asse …
Osteomyelitis Pipeline constitutes 5+ key companies continuously working towards developing 5+ Osteomyelitis treatment therapies, analyzes DelveInsight.
Osteomyelitis Overview:
Osteomyelitis is a severe bone infection that can be…
Persistent Epithelial Defects Clinical and Non-Clinical Studies, Key Companies, …
Persistent Epithelial Defects Pipeline constitutes 5+ key companies continuously working towards developing 5+ Persistent Epithelial Defects treatment therapies, analyzes DelveInsight.
Persistent Epithelial Defects Overview:
The cornea is…
Postpartum Depression Clinical and Non-Clinical Studies, Key Companies, Therapeu …
Postpartum Depression Pipeline constitutes 2+ key companies continuously working towards developing 2+ Postpartum Depression treatment therapies, analyzes DelveInsight.
Postpartum Depression Overview:
The arrival of a baby can…
Obesity Therapeutics Market Size in the 7MM is expected to increase by study per …
DelveInsight's "Obesity Market Insights, Epidemiology and Market Forecast-2034" report delivers an in-depth understanding of obesity, historical and forecasted epidemiology as well as the obesity market…
Neuropathic Ocular Pain Treatment Market Size is anticipated to grow at a substa …
DelveInsight's "Neuropathic Ocular Pain Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the NOP, historical and forecasted epidemiology as…
Hairy Cell Leukemia Treatment Market in the 7MM is expected to increase by study …
DelveInsight's "Hairy Cell Leukemia Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of historical and forecasted epidemiology as well as…
Graves' Ophthalmopathy Therapeutics Market Size was ~USD 2,600 million in 2023, …
DelveInsight's "Graves Ophthalmopathy Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of the Graves Ophthalmopathy, historical and forecasted epidemiology as…
Peripheral Arterial Disease Clinical Trials Studies Analysis, Key Companies, The …
Peripheral Arterial Disease Pipeline constitutes 20+ key companies continuously working towards developing 22+ Peripheral Arterial Disease treatment therapies, analyzes DelveInsight.
Peripheral Arterial Disease Overview:
Peripheral artery disease…
Chimeric Antigen Receptor T-Cell Therapy (CAR-T) Clinical and Non-Clinical Studi …
Chimeric Antigen Receptor T-Cell Therapy (CAR-T) Pipeline constitutes 180+ key companies continuously working towards developing 200+ Chimeric Antigen Receptor T-Cell Therapy (CAR-T) treatment therapies, analyzes…
Postoperative Pain Clinical and Non-Clinical Studies, Key Companies, Therapeutic …
Postoperative Pain Pipeline constitutes 45+ key companies continuously working towards developing 50+ Postoperative Pain treatment therapies, analyzes DelveInsight.
Postoperative Pain Overview:
Postoperative or postsurgical pain is defined…
Polymyalgia Rheumatica Clinical and Non-Clinical Studies, Key Companies, Therape …
Polymyalgia Rheumatica Pipeline constitutes 5+ key companies continuously working towards developing 5+ Polymyalgia Rheumatica treatment therapies, analyzes DelveInsight.
Polymyalgia Rheumatica Overview:
Polymyalgia rheumatica (PMR) is a rheumatic…
Peripheral t cell lymphomas (PTCL) Clinical and Non-Clinical Studies, Key Compan …
Peripheral t cell lymphomas (PTCL) Pipeline constitutes 40+ key companies continuously working towards developing 40+ Peripheral t cell lymphomas (PTCL) treatment therapies, analyzes DelveInsight.
Peripheral t…
Glioblastoma Pipeline Therapeutics Assessment, Treatment Drugs, Clinical Trials, …
DelveInsight's, "Glioblastoma Pipeline Insight 2024" report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in Glioblastoma pipeline landscape. It covers the pipeline drug…
Gastric Cancer Pipeline, Treatment Drugs, Clinical Trials and Companies 2024 (Up …
DelveInsight's, "Gastric Cancer Pipeline Insight 2024" report provides comprehensive insights about 200+ companies and 220+ pipeline drugs in Gastric Cancer pipeline landscape. It covers the…
COVID-19 Pipeline Insights, Clinical Trials, Treatment Drugs, and Companies 2024 …
DelveInsight's, "Covid-19 Pipeline Insight 2024" report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in Covid-19 pipeline landscape. It covers the pipeline drug…
B-Cell Lymphomas Pipeline Insights, Treatment Drugs, Clinical Trials and Compani …
DelveInsight's, "B-cell Lymphoma- Pipeline Insight, 2024" report provides comprehensive insights about 295+ companies and 300+ pipeline drugs in B-cell Lymphoma pipeline landscape. It covers the…
Adeno-Associated Virus (AAV) Vectors in Gene Therapy Pipeline Therapeutics, Clin …
DelveInsight's, "Adeno-Associated Virus (AAV) Vectors in Gene Therapy- Pipeline Insight, 2024" report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in Adeno-Associated Virus…
Small Cell Lung Cancer Pipeline Therapeutics, Clinical Trials, Treatment Drugs, …
DelveInsight's, "Small Cell Lung Cancer Pipeline Insight 2024" report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Small Cell Lung Cancer pipeline…
Breast Cancer Pipeline Therapeutics, Treatment Drugs, Clinical Trials, and Compa …
DelveInsight's, "Breast Cancer Pipeline Insight 2024" report provides comprehensive insights about 120+ Breast Cancer companies and 130+ pipeline drugs in the Breast Cancer pipeline landscape.…
Bladder Cancer Pipeline Insights, Treatment Drugs, Companies and Clinical Trials …
DelveInsight's, "Bladder Cancer Pipeline Insight 2024" report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in the Bladder cancer pipeline landscape. It covers…
Asthma Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Asthma Pipeline Insight 2024" report provides comprehensive insights about 80+ companies and 90+ pipeline drugs in Asthma pipeline landscape. It covers the pipeline drug…
Non-Hodgkin Lymphoma Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Non-Hodgkin Lymphoma Pipeline Insight" report provides comprehensive insights about 200+ companies and 220+ pipeline drugs in the Non-Hodgkin Lymphoma pipeline landscape. It covers the…
Clear Cell Carcinoma Market to Show a Rise During the Study Period |F. Hoffmann- …
DelveInsight's "Clear Cell Carcinoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Clear Cell Carcinoma, historical and forecasted epidemiology as…
Chronic Liver Disease Market to Show a Rise During the Study Period | Abbott Lab …
DelveInsight's "Chronic Liver Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Chronic Liver Disease, historical and forecasted epidemiology as…
Chronic Hemodialysis Market to Show a Rise During the Study Period | Fresenius M …
DelveInsight's "Chronic Hemodialysis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Chronic Hemodialysis, historical and forecasted epidemiology as well as…
Chronic Brain Damage Market to Show a Rise During the Study Period | NeuroVive P …
DelveInsight's "Chronic Brain Damage Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Chronic Brain Damage, historical and forecasted epidemiology as…
Chiari Malformation Market to Show a Rise During the Study Period | Pfizer Inc., …
DelveInsight's "Chiari Malformation Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Chiari Malformation, historical and forecasted epidemiology as well as…
Chemotherapy-induced Hearing Loss Market to Show a Rise During the Study Period …
DelveInsight's "Chemotherapy-induced Hearing Loss Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Chemotherapy-induced Hearing Loss, historical and foreacasted epidemiology as…
Ovarian Cancer Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Ovarian Cancer Pipeline Insight 2024" report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in the Ovarian Cancer pipeline landscape. It covers…
Acute Ischemic Stroke Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Acute Ischemic Stroke Pipeline Insight 2024" report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Acute Ischemic Stroke pipeline landscape. It…
Relapsed/Refractory Acute Myeloid Pipeline Therapeutics Assessment Report 2024 ( …
DelveInsight's, "Relapsed/refractory acute myeloid leukemia (AML) Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 75+ pipeline drugs in Relapsed/refractory acute myeloid leukemia…
Treatment Resistant Depression Pipeline Therapeutics Assessment Report 2024 (Upd …
DelveInsight's, "Treatment Resistant Depression Pipeline Insight 2024" report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in Treatment Resistant Depression pipeline landscape. It…
Non-Hodgkin's Lymphoma Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Non-Hodgkin Lymphoma Pipeline Insight" report provides comprehensive insights about 200+ companies and 220+ pipeline drugs in the Non-Hodgkin Lymphoma pipeline landscape. It covers the…
CAR-T Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "CAR-T Pipeline Insight 2024" report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in CAR-T pipeline landscape. It covers the pipeline drug…
Parkinson's Disease Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Parkinson's Disease Pipeline Insight 2024" report provides comprehensive insights about 130+ companies and 150+ pipeline drugs in Parkinson's Disease pipeline landscape. It covers the…
HR+ HER2-ve Breast Cancer Pipeline Therapeutics Assessment Report 2024 | DelveIn …
DelveInsight's, "HR Positive/ HER2 Negative Breast Cancer Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 53+ pipeline drugs in HR Positive/ HER2…
Sturge-weber Syndrome Market 2032 | Pfizer, Qlaris Bio, GW Pharmaceuticals, IDEA …
DelveInsight's "Sturge-weber Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Sturge-weber Syndrome, historical and forecasted epidemiology as well as the…
Amyotrophic Lateral Sclerosis Market 2034 | Mitsubishi Tanabe Pharma Corporation …
DelveInsight's "Amyotrophic Lateral Sclerosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Amyotrophic Lateral Sclerosis, historical and forecasted epidemiology as well…
Chronic Liver Disease Market Report 2032 | Major players involved- Novo Nordisk …
DelveInsight's "Chronic Liver Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Chronic Liver Disease, historical and forecasted epidemiology as well…
Catheter-related Bloodstream Infections Market Report 2034 | Major players inclu …
DelveInsight's "Catheter-related Bloodstream Infections Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of Catheter-related Bloodstream Infections, historical and forecasted epidemiology as well…
Neuronal Ceroid-Lipofuscinoses Market 2032 |Pfizer, Spark Therapeutics, REGENXBI …
DelveInsight's "Neuronal Ceroid-Lipofuscinoses Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Neuronal Ceroid-Lipofuscinoses Disease, historical and forecasted epidemiology as well…
Food Allergy Market to Rise by 2034 | Aimmune Therapeutics, Inc., Novartis Pharm …
DelveInsight's "Food Allergy Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of Food Allergy, historical and forecasted epidemiology as well as the…
Metastatic Melanoma Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Metastatic Melanoma Pipeline Insight 2024" report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in Metastatic Melanoma pipeline landscape. It covers the…
Melanoma Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Melanoma Pipeline Insight 2024" report provides comprehensive insights about 150+ companies and 170+ pipeline drugs in Melanoma pipeline landscape. It covers the pipeline drug…
